CTLA4 and melanoma: In the immune microenvironment of melanoma, cytotoxic T-lymphocyte-associated protein-4 and programmed cell death protein-1 on the T-cell membrane bind to ligands on dendritic cells, thereby attenuating tumor immunity and leading to tumor progression [16].